Free Trial

Kinaxis (TSE:KXS) Given New C$185.00 Price Target at BMO Capital Markets

Kinaxis logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • BMO Capital Markets raised its price target on Kinaxis to C$185 from C$180, implying about 16.8% upside from the stock’s current price.
  • Analyst sentiment remains positive overall, with six Buy ratings and one Hold; however, several firms recently trimmed their targets, and the average target is C$201.78.
  • Kinaxis shares rose to C$158.40 on Friday after the company reported C$1.45 EPS and C$230.19 million in quarterly revenue in its latest earnings release.
  • Five stocks to consider instead of Kinaxis.

Kinaxis (TSE:KXS - Get Free Report) had its price target hoisted by equities researchers at BMO Capital Markets from C$180.00 to C$185.00 in a research report issued to clients and investors on Friday,BayStreet.CA reports. BMO Capital Markets' target price would indicate a potential upside of 16.79% from the stock's current price.

Other equities analysts have also issued research reports about the company. Canadian Imperial Bank of Commerce lowered their price objective on Kinaxis from C$203.00 to C$171.00 in a research note on Friday, April 17th. Canaccord Genuity Group reduced their price target on Kinaxis from C$225.00 to C$200.00 in a report on Friday, March 6th. Stifel Nicolaus lowered their price target on shares of Kinaxis from C$245.00 to C$200.00 and set a "buy" rating on the stock in a research report on Wednesday. TD Securities cut their price objective on shares of Kinaxis from C$229.00 to C$200.00 and set a "buy" rating for the company in a research report on Friday, March 6th. Finally, Royal Bank Of Canada reduced their target price on shares of Kinaxis from C$235.00 to C$200.00 and set an "outperform" rating on the stock in a research note on Monday, January 26th. Six analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, Kinaxis presently has an average rating of "Moderate Buy" and an average price target of C$201.78.

View Our Latest Report on KXS

Kinaxis Price Performance

TSE KXS traded up C$5.44 during trading hours on Friday, hitting C$158.40. 92,942 shares of the company's stock traded hands, compared to its average volume of 138,576. The company has a market capitalization of C$4.38 billion, a PE ratio of 64.65, a PEG ratio of 3.60 and a beta of 0.68. The company has a debt-to-equity ratio of 11.39, a current ratio of 1.97 and a quick ratio of 2.29. Kinaxis has a 52-week low of C$117.22 and a 52-week high of C$212.45. The firm's 50-day moving average is C$138.87 and its 200-day moving average is C$153.99.

Kinaxis (TSE:KXS - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported C$1.45 earnings per share for the quarter. The business had revenue of C$230.19 million for the quarter. Kinaxis had a net margin of 12.90% and a return on equity of 16.46%. Equities analysts forecast that Kinaxis will post 4.2526231 EPS for the current fiscal year.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

Featured Stories

Analyst Recommendations for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines